Choosing in Advanced NSCLC - Without AGA, and...

In this episode, Dr. Barb Melosky takes us through practical aspects of using HER2 targeted agents in HER2 altered advanced NSCLC. This is particularly timely given we now have access through company sponsored SAP programs for both Zongertinib and Sevabertinib. 

In this episode, Dr. Scott Berry takes us through practical discussions on sequencing the increasing available treatment options for Advanced Colorectal cancer. 

In the next podcast episode, we will continue our talk on hemophilia. Specifically the treatment of hemophilia. We'll discuss the different types of therapy available, from traditional factor replacement to emerging gene-techniques. Join Dr. Niket Sonpal as he helps us manage hem ...  Show more

In this episode, we delve into the groundbreaking study "Influence of therapeutic plasma exchange treatment on short-term mortality of critically ill adult patients with sepsis-induced organ dysfunction." We explore how Therapeutic Plasma Exchange (TPE) could revolutionize the tr ...  Show more

In this 268th episode I welcome Drs. Carullo, Kostibas, Isaac, Banks and Segna to the show. They are our peds, cardiac, OB, critical care and regional fellowship directors and we discuss the state of fellowships in anesthesiology.Our Sponsors:* Check out BetterHelp: https://www.b ...  Show more

Hypercholesterolemia is common condition with serious consequences. It is important that we assess, diagnose and manage it appropriately. To find out more about this problem and what we can do about it, please do listen to this BMJ Best Practice podcast interview with Thorsten Le ...  Show more